Singapore markets closed
Straits Times Index
3,426.47 -3.98 (-0.12%) Nikkei
37,667.41 -202.10 (-0.53%) Hang Seng
17,021.31 +16.34 (+0.10%) FTSE 100
8,285.71 +99.36 (+1.21%) Bitcoin USD
67,982.68 +878.80 (+1.31%) CMC Crypto 200
1,375.17 +44.56 (+3.35%)
Aadi Bioscience, Inc. (AADI)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 38.80M |
| Enterprise value | -48.31M |
| Trailing P/E | 1.89 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.79 |
| Price/book (mrq) | 0.43 |
| Enterprise value/revenue | 3.48 |
| Enterprise value/EBITDA | -0.62 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.31 |
| 52-week change 3 | -70.36% |
| S&P500 52-week change 3 | 18.96% |
| 52-week high 3 | 7.2400 |
| 52-week low 3 | 1.2800 |
| 50-day moving average 3 | 1.6494 |
| 200-day moving average 3 | 2.5062 |
Share statistics
| Avg vol (3-month) 3 | 219.82k |
| Avg vol (10-day) 3 | 125.25k |
| Shares outstanding 5 | 24.55M |
| Implied shares outstanding 6 | 24.55M |
| Float 8 | 16.05M |
| % held by insiders 1 | 10.81% |
| % held by institutions 1 | 53.98% |
| Shares short (15 Jul 2024) 4 | 233.24k |
| Short ratio (15 Jul 2024) 4 | 0.69 |
| Short % of float (15 Jul 2024) 4 | 1.41% |
| Short % of shares outstanding (15 Jul 2024) 4 | 0.95% |
| Shares short (prior month 14 Jun 2024) 4 | 914.38k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:15 |
| Last split date 3 | 27 Aug 2021 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -288.72% |
| Operating margin (ttm) | -364.51% |
Management effectiveness
| Return on assets (ttm) | -33.11% |
| Return on equity (ttm) | -58.22% |
Income statement
| Revenue (ttm) | 23.84M |
| Revenue per share (ttm) | 0.88 |
| Quarterly revenue growth (yoy) | -8.80% |
| Gross profit (ttm) | N/A |
| EBITDA | -74.44M |
| Net income avi to common (ttm) | -68.83M |
| Diluted EPS (ttm) | -2.5500 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 88.27M |
| Total cash per share (mrq) | 3.6 |
| Total debt (mrq) | 1.16M |
| Total debt/equity (mrq) | 1.29% |
| Current ratio (mrq) | 5.16 |
| Book value per share (mrq) | 3.68 |
Cash flow statement
| Operating cash flow (ttm) | -58.01M |
| Levered free cash flow (ttm) | -35.58M |
© 2024 Yahoo. All rights reserved.